SCHEMBL6473778

SCHEMBL6473778

COC(=O)[C@H](Cc1ccc(OC(=O)N2CCC(NC(=O)Cc3ccccc3)CC2)cc1)NC(=O)[C@H](CC(C)C)NC(=O)CBr

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
YAP1 P46937 4/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
PSMB11 A5LHX3 2/20 0.49
PSMA7 O14818 2/20 0.49
PSMB1 P20618 2/20 0.49
PSMA1 P25786 2/20 0.49
PSMA2 P25787 2/20 0.49
PSMA3 P25788 2/20 0.49
PSMA4 P25789 2/20 0.49
PSMB8 P28062 2/20 0.49
PSMB9 P28065 2/20 0.49
PSMA5 P28066 2/20 0.49
PSMB4 P28070 2/20 0.49
PSMB6 P28072 2/20 0.49
PSMB5 P28074 2/20 0.49
PSMB10 P40306 2/20 0.49
PSMB3 P49720 2/20 0.49
PSMB2 P49721 2/20 0.49
PSMA6 P60900 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6479141 0.89 MAPK1 (0.54) YAP1MEN1KMT2APSMB11PSMA7
Hydrochloric Acid SCHEMBL6473826 0.88 KMT2A (0.50) YAP1MEN1KMT2APSMB11PSMA7
SCHEMBL6474003 0.88 PSMB11 (0.47) YAP1MEN1KMT2APSMB11PSMA7
SCHEMBL6666207 0.82 CAPN1 (0.45) YAP1PSMB11PSMA7PSMB1PSMA1
SCHEMBL6472845 0.81 MEN1 (0.46) YAP1MEN1KMT2APSMB11PSMA7
SCHEMBL6473896 0.81 PSMB11 (0.44) YAP1MEN1KMT2APSMB11PSMA7
SCHEMBL6480791 0.80 YAP1 (0.46) YAP1MEN1KMT2APSMB11PSMA7
SCHEMBL6473601 0.79 PSMB11 (0.44) YAP1MEN1KMT2APSMB11PSMA7
SCHEMBL6472835 0.79 CASP1 (0.51) YAP1MEN1KMT2APSMB11PSMA7
SCHEMBL6480346 0.78 PSMB11 (0.46) PSMB11PSMA7PSMB1PSMA1PSMA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6867192-B1 Compounds useful in the treatment of inflammatory diseases GLAXO GROUP LIMITED (GB) 2005-03-15 US disclosed
EP-1140837-B1 COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LTD (GB) 2004-08-18 EP disclosed